Maurice Chagnaud
Director/Board Member at TORRENT PHARMACEUTICALS LIMITED
Profile
Maurice Chagnaud is the founder of Mac Healthcare Consulting AG, which was founded in 2017.
He is currently an Independent Director at Torrent Pharmaceuticals Ltd., a Director at Remedica Ltd., and an Independent Member-Supervisory Board at Farmak JSC.
He previously served as the Chief Executive Officer at Polpharma SA from 2015 to 2016, and as the Group President at Lupin Ltd.
from 2014 to 2015.
He was also the Chief Commercial Officer at Teva Pharmaceuticals Europe BV.
Additionally, he was an Independent Non-Executive Director at Advanz Pharma Corp.
Ltd.
and a Principal at Global Frontier Partners LP.
Dr. Chagnaud holds an MBA and a doctorate from Institut d’Administration des Entreprises.
Maurice Chagnaud active positions
| Companies | Position | Start |
|---|---|---|
| TORRENT PHARMACEUTICALS LIMITED | Director/Board Member | 2022-05-10 |
| FARMAK | Director/Board Member | 2022-06-06 |
| Mac Healthcare Consulting AG | Chief Executive Officer | 2017-09-30 |
Remedica Ltd.
 Remedica Ltd. Pharmaceuticals: MajorHealth Technology Remedica Ltd. manufactures and distributes of pharmaceutical products. It provides a variety of tablets, cream, film coated tablets, chewable medicines for different therapeutic category. The company was founded by Chris Pattichis in 1960 and is headquartered in Limassol, Cyprus. | Director/Board Member | - |
Former positions of Maurice Chagnaud
| Companies | Position | End |
|---|---|---|
| Global Frontier Partners LP | Corporate Officer/Principal | 2017-08-31 |
Polpharma SA
 Polpharma SA Pharmaceuticals: MajorHealth Technology Polpharma SA develops and manufactures generic drugs. It offers food for special medical purposes, on prescription, no prescription, and medical products. The company was founded in 1935 and is headquartered in Starogard Gdanski, Poland. | Chief Executive Officer | 2016-05-31 |
| LUPIN LIMITED | President | 2015-08-31 |
| ADVANZ PHARMA CORP. LIMITED | Director/Board Member | - |
Teva Pharmaceuticals Europe BV
 Teva Pharmaceuticals Europe BV MiscellaneousMiscellaneous Part of Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals Europe BV operates as an investment holding Dutch company and wholesales pharmaceutical goods and raw materials. The private company is based in Haarlem, Netherlands. | Corporate Officer/Principal | - |
Training of Maurice Chagnaud
| Institut d’Administration des Entreprises | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| TORRENT PHARMACEUTICALS LIMITED | Health Technology |
| LUPIN LIMITED | Health Technology |
| FARMAK | Health Technology |
| Private companies | 6 |
|---|---|
| Global Frontier Partners LP | Miscellaneous |
Polpharma SA
Polpharma SA Pharmaceuticals: MajorHealth Technology Polpharma SA develops and manufactures generic drugs. It offers food for special medical purposes, on prescription, no prescription, and medical products. The company was founded in 1935 and is headquartered in Starogard Gdanski, Poland. | Health Technology |
Teva Pharmaceuticals Europe BV
Teva Pharmaceuticals Europe BV MiscellaneousMiscellaneous Part of Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals Europe BV operates as an investment holding Dutch company and wholesales pharmaceutical goods and raw materials. The private company is based in Haarlem, Netherlands. | Miscellaneous |
Remedica Ltd.
Remedica Ltd. Pharmaceuticals: MajorHealth Technology Remedica Ltd. manufactures and distributes of pharmaceutical products. It provides a variety of tablets, cream, film coated tablets, chewable medicines for different therapeutic category. The company was founded by Chris Pattichis in 1960 and is headquartered in Limassol, Cyprus. | Health Technology |
Advanz Pharma Corp. Ltd.
 Advanz Pharma Corp. Ltd. Pharmaceuticals: MajorHealth Technology ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. The firm specializes in anti-Infectives and endocrinology therapy areas. It operates through the following segments: Advanz Pharma International; Advanz Pharma North America; and Corporate. The Advanz Pharma International segment include portfolio of branded and generic products that are sold to wholesalers, hospitals, and pharmacies. The Advanz Pharma North America segment comprises branded products and authorized generic contracts that focuses primarily on the U.S. pharmaceutical market. The Corporate segment represents the centralized costs. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in St. Helier, the United Kingdom. | Health Technology |
| Mac Healthcare Consulting AG |
- Stock Market
- Insiders
- Maurice Chagnaud
